Dallas VA Medical Center [clinicaltrials_resource:5fa70d545417748aa57e5f2125176f35]
Stuart J Spechler, MD [clinicaltrials_resource:075f4f5fcc237ef5bc430c80e52049e0]Subhash Banerjee, MD [clinicaltrials_resource:08a996ea492ecdd84cac0155597844b7]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Roger Bedimo, M.D. [clinicaltrials_resource:1777b2e387d67f7bc5253e824fb4509f]Stuart J Spechler, MD [clinicaltrials_resource:186a5888def4b7ab6528396759c5c885]Carlos H Timaran, MD [clinicaltrials_resource:2f2298af989a2c09442a89c26b3179a5]Stuart J Spechler, MD [clinicaltrials_resource:4604a8b992412a0ce1d4f6e693d1dc3a]Stuart J Spechler, MD [clinicaltrials_resource:4962647c85318f35b243c94b41b4bcd1]Byron Cryer, MD [clinicaltrials_resource:5b098891b751d9240384734536109c74]Carlos H Timaran, MD [clinicaltrials_resource:5c3823f6f3efe840fb126354ba483fb7]Stuart J Spechler, MD [clinicaltrials_resource:6655e91114fd3e3ec87270bb77386787]Linda A Feagins, MD [clinicaltrials_resource:82604b83f16abb96238b144e5a21c38a]Salahuddin Kazi, MBBS [clinicaltrials_resource:8fd884b3e8deaddb48900e20019aeb29]Stuart J Spechler, MD [clinicaltrials_resource:9003ea289a3bba031020ca48f12951b8]Stuart J Spechler, MD [clinicaltrials_resource:9e3d8101f44e840e030341e77a3b651c]Geetha Shivakumar, M.D., M.S. [clinicaltrials_resource:a976ddcab8c8ba1340e8acf534a92052]Carlos H Timaran, MD [clinicaltrials_resource:b2ec5ddfd38c405c6601643487403990]Stuart J Spechler, MD [clinicaltrials_resource:e248c162ebef08b1b67efc00d44076a7]
affiliation [clinicaltrials_vocabulary:affiliation]
Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population [clinicaltrials:NCT00431405]Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [clinicaltrials:NCT00677300]clinicaltrials:NCT01404832Exacerbating Factors in Inflammatory Bowel Disease [clinicaltrials:NCT01405105]Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting [clinicaltrials:NCT01414387]Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection [clinicaltrials:NCT01723059]clinicaltrials:NCT01733810
collaborator [clinicaltrials_vocabulary:collaborator]
Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population [clinicaltrials:NCT00431405]Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [clinicaltrials:NCT00677300]clinicaltrials:NCT00830232Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments [clinicaltrials:NCT00925483]Optimal Suture Choice for Improved Scar Outcomes [clinicaltrials:NCT00938691]Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery [clinicaltrials:NCT00953784]Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors [clinicaltrials:NCT00954148]Effectiveness for Interventions to Minimize Surgical Site Infections [clinicaltrials:NCT01153191]clinicaltrials:NCT01404832Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy) [clinicaltrials:NCT01405092]Exacerbating Factors in Inflammatory Bowel Disease [clinicaltrials:NCT01405105]Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting [clinicaltrials:NCT01414387]Prone Versus Left-sided Colonoscopy in Obese Patients [clinicaltrials:NCT01616602]Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study [clinicaltrials:NCT01647568]Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection [clinicaltrials:NCT01723059]clinicaltrials:NCT01733810
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population [clinicaltrials:NCT00431405]Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [clinicaltrials:NCT00677300]clinicaltrials:NCT00830232Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments [clinicaltrials:NCT00925483]Optimal Suture Choice for Improved Scar Outcomes [clinicaltrials:NCT00938691]Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery [clinicaltrials:NCT00953784]Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors [clinicaltrials:NCT00954148]Effectiveness for Interventions to Minimize Surgical Site Infections [clinicaltrials:NCT01153191]clinicaltrials:NCT01404832Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy) [clinicaltrials:NCT01405092]Exacerbating Factors in Inflammatory Bowel Disease [clinicaltrials:NCT01405105]Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting [clinicaltrials:NCT01414387]clinicaltrials:NCT01440634Prone Versus Left-sided Colonoscopy in Obese Patients [clinicaltrials:NCT01616602]Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study [clinicaltrials:NCT01647568]Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection [clinicaltrials:NCT01723059]clinicaltrials:NCT01733810
source [clinicaltrials_vocabulary:source]
Dallas VA Medical Center [clinicaltrials_resource:5fa70d545417748aa57e5f2125176f35]
Bio2RDF identifier
5fa70d545417748aa57e5f2125176f35
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5fa70d545417748aa57e5f2125176f35
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:5fa70d545417748aa57e5f2125176f35
title
Dallas VA Medical Center
@en
type
label
Dallas VA Medical Center [clinicaltrials_resource:5fa70d545417748aa57e5f2125176f35]
@en